Aspirin protected the nitric oxide/cyclic GMP generating system in human peritoneum

Area of Science:

• Cell Biology
• Inflammation Research
• Pharmacology

Background:

• Peritoneal dysfunction is linked to inflammation and altered endothelial nitric oxide synthase (eNOS) expression.
• Understanding molecular changes in the peritoneum during inflammation is crucial for developing therapeutic strategies.

Purpose of the Study:

• To investigate the impact of Escherichia coli lipopolysaccharide (LPS) on eNOS expression in human peritoneal tissue.
• To evaluate the protective effect of aspirin on LPS-induced changes in eNOS and related signaling pathways.

Main Methods:

• Human peritoneal tissue samples were treated with LPS to induce an inflammatory response.
• Western blotting or similar techniques were used to quantify eNOS and soluble guanylate cyclase (sGC) protein levels.
• The effects of varying aspirin concentrations on eNOS and sGC expression were assessed in LPS-stimulated samples.

Main Results:

• LPS significantly reduced eNOS protein levels in a time-dependent manner, primarily affecting capillary endothelial and mesothelial cells.
• Aspirin, at anti-inflammatory doses, effectively restored eNOS expression in LPS-treated peritoneal tissue.
• LPS also downregulated sGC, the main intracellular nitric oxide (NO) receptor, an effect reversed by aspirin.

Conclusions:

• The eNOS-sGC signaling pathway in the peritoneum is downregulated by LPS-induced inflammation.
• Aspirin demonstrates a protective effect on both eNOS and sGC protein expression in the human peritoneum.
• These findings highlight a potential new mechanism for aspirin in mitigating peritoneal dysfunction during inflammation.